Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹15 Cr
Revenue (TTM)
₹12 Cr
Net Profit (TTM)
₹1 Cr
ROE
10.2 %
ROCE
14.2 %
P/E Ratio
14.1
P/B Ratio
1.4
Industry P/E
17.53
EV/EBITDA
8.4
Div. Yield
0 %
Debt to Equity
0.3
Book Value
₹63
EPS
₹6.1
Face value
10
Shares outstanding
1,681,500
CFO
₹-6.66 Cr
EBITDA
₹6.08 Cr
Net Profit
₹3.96 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
EP Biocomposites
| -16.7 | -4.3 | -16.7 | -29.8 | -24.5 | -- | -- |
|
*
| -- | -- | -- | -- | -- | -- | -- |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
EP Biocomposites
| -47.0 | -8.5 | -0.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
| -1.3 | 28.1 | 69.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
EP Biocomposites
|
86.6 | 14.6 | 12.0 | 1.0 | -- | 10.2 | 14.1 | 1.4 |
| 430.5 | 1,223.7 | 1,010.1 | 100.9 | 11.5 | 9.4 | 14.8 | 1.7 | |
| 283.2 | 586.1 | 558.8 | 49.6 | 9.9 | 10.6 | 12.3 | 1.1 | |
| 335.8 | 648.0 | 39.3 | 17.9 | 54.9 | 18.6 | 36.9 | 6.4 | |
| 172.3 | 296.5 | 77.8 | 17.6 | 29.3 | 14.7 | 17.4 | 2.0 | |
| 1,295.1 | 9,578.9 | 4,129.6 | 381.4 | 9.2 | 17.6 | 25.1 | 4.1 | |
| 147.6 | 337.5 | 149.8 | 8.5 | -- | 13.6 | 39.9 | 3.8 | |
| 48.4 | 334.4 | 195.8 | 15.4 | 6.6 | 11 | 24.8 | 2.5 | |
| 232.0 | 200.9 | 43.8 | 15.7 | -- | 15.4 | 12.8 | 1.6 | |
| 608.4 | 1,100.1 | 517.9 | 46.9 | 13.7 | 21.8 | 22.9 | 3.9 |
No Review & Analysis are available.
Manufacture of other cement and asbestos cement products n.e.c.
Incorporated
2020
Chairman
--
Managing Director
Rajkumar Kamat
Headquarters
Bicholim, Goa
Website
Looking for more details about EP Biocomposites Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of EP Biocomposites Ltd is ₹86.60 (BSE) as of 01-Apr-2026 IST. EP Biocomposites Ltd has given a return of -24.53% in the last 3 years.
The P/E ratio of EP Biocomposites Ltd is 14.13 times as on 01-Apr-2026, a 19 discount to its peers’ median range of 17.53 times.
The P/B ratio of EP Biocomposites Ltd is 1.37 times as on 01-Apr-2026, a 46 discount to its peers’ median range of 2.53 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
20.13
|
1.96
|
|
2024
|
20.06
|
2.41
|
|
2023
|
58.81
|
4.03
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of EP Biocomposites Ltd are Rs 149.90 and Rs 75.50 as of 03-Apr-2026.
EP Biocomposites Ltd has a market capitalisation of ₹ 15 Cr as on 01-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in EP Biocomposites Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.60
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.